Pink SheetThe newly rescheduled meeting of the US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) will be shorter than the delayed February meeting, likely refle
Pink SheetThe US Food and Drug Administration’s approval of two new vaccines places the spotlight on what would normally be a routine next step on the road to market, the US Center for Disease Control and Preve
ScripValneva’s attempts to expand access for Ixchiq, the world’s first vaccine for chikungunya, to all age groups have been boosted by positive clinical trial readouts in children and adolescents. The Fren
Pink SheetThe US Food and Drug Administration’s expectations for the timing of accelerated approval confirmatory trials came into clearer focus in 2024 with new policy documents and real-world examples. The age